--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Blood Pressure Monitor: AVAX" developer_entity: "Matthias Kluett" bundle_id: "app.avax.health" app_store_id: "1493789680" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-07-15" report_date: "2026-08-20" last_verified: "2026-08-20T00:00:00.000Z" report_version: "8.6.1" total_reviews: 10483 overall_rating: 4.4 sentiment: "Mixed" sentiment_score: 45 confidence: "medium" confidence_score: 0.65 top_praise_theme: "Manual tracking of blood pressure and weight provides actionable health insights for doctor consultations" top_complaint_theme: "Intrusive full-screen advertisements disrupt the user experience and make navigation difficult for free users" review_sample_size: 51 total_review_count: 51 analyzed_review_count: 51 data_age_days: 41 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "freemium", "mixed sentiment", "mobile app", "app review", "app analysis", "individuals", "managing", "hypertension"] canonical_url: "https://marlvel.ai/apps/blood-pressure-monitor-avax" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Blood Pressure Monitor: AVAX Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 4.38 · Sentiment Mixed - **Recent focus**: Intrusive full-screen advertisements disrupt the user experience and make navigation difficult for free users (top complaint) · Manual tracking of blood pressure and weight provides actionable health insights for doctor consultations (top praise) > **TL;DR:** Blood Pressure Monitor: AVAX is a medical app by Matthias Kluett, rated 4.38/5 by 10.5K users, with Mixed user sentiment (45/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Blood Pressure Monitor: AVAX shows Mixed sentiment (4.38/5 from 10.5K reviews) - users praise manual tracking of blood pressure and weight provides actionable health insights for doctor consultations but report issues with intrusive full-screen advertisements disrupt the user experience and make navigation difficult for free users. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.38/5 (10.5K reviews) | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | Matthias Kluett | | **Pricing** | Freemium | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.65/1.0) | | **Data Age** | 41d | ## Metadata & Market Performance - **Publisher:** Matthias Kluett - **Category:** Medical - **Target Audience:** Individuals managing hypertension or cardiovascular health requiring digital logs for medical review. - **Platforms:** iOS & Android - **Version Reviewed:** 8.6.0 - **Report Date:** 2026-08-20 - **Signal Count:** 51 reviews analyzed - **Confidence:** Medium (0.65/1.0) - **App Store ID (iOS):** 1493789680 - **Bundle ID:** app.avax.health - **Google Play ID:** app.avax.health - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-20 - **Short Description:** Your blood pressure tracker app - Start analyzing now - Made in Germany ## Executive Snapshot **What it is:** Blood Pressure Monitor: AVAX is a medical diary app for tracking vital signs and medication on iOS and Android. **Why users hire it:** It removes the cognitive cost of manual paper logging for hypertension patients, though the current build's stability issues undermine this utility. ## App DNA (Features & Intent) - **[Differentiator] Anonymous Mode:** Allows full app functionality without account creation, lowering the barrier to entry. - **[Standard] PDF Reporting:** Generates medical reports for doctor consultation, gated behind a premium tier. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Blood Pressure Monitor: AVAX maintains a presence in the medical category with a 4.37 rating on Android and 4.76 on iOS. The gap between its free-tier ad density and the premium-gated reporting feature creates a monetization friction point that limits long-term retention. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free tier with unlimited data logging, Premium membership for automated PDF reports - **Analysis:** The freemium model gates professional reporting behind a premium tier while using free core logging to maximize the user base. ## 🟡 User Sentiment (Medium Confidence: 51 of 51 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.38/5 - **Platform Split:** iOS 4.8/5 (137 ratings) | Android 4.4/5 (10.3K ratings) - **Overall Sentiment:** Mixed ### Top Praises - **Manual tracking of blood pressure and weight provides actionable health insights for doctor consultations** - **The interface allows for quick and efficient data entry during daily health monitoring routines** ### Top Complaints (Impact Areas) - **Intrusive full-screen advertisements disrupt the user experience and make navigation difficult for free users** ## SWOT Analysis {#swot} **Core Strengths:** - Anonymous mode removes account-creation friction **Growth Levers:** - Third-party health platform integration reduces manual entry ## Recent Changes (v2 → v3) {#recent-changes} The analysis has shifted from a neutral observation of features to a critical assessment of the app's architectural limitations, specifically identifying the anonymous-use mode as a barrier to data recovery. The competitive outlook has hardened, explicitly linking the lack of third-party health platform integration to the app's declining market relevance. **Overall trend**: Declining **Compared at**: 2026-08-20 ### High-impact changes - **[Shifted] Anonymous Mode Risk Assessment** (positioning) - **[Declined] Market Outlook Hardening** (positioning) ### Medium-impact changes - **[Removed] Bluetooth Integration Strength** (swot) ## What's New - **Latest (v8.6.1, 1 months ago):** Addressed general stability issues and minor bug fixes. ## App Momentum (Maintenance) {#momentum} - Ships bug fixes at 6-week cadence. - No new feature builds recently. > **Cadence:** 2 total versions · 0 majors in last 6 months · 36 days since last update · 29 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Blood Pressure Monitor: AVAX is a medical app that is free with in-app purchases. With a 4.38/5 rating from 10.5K reviews, it shows mixed user reception. > **Bottom Line:** Stabilizing the core data-persistence layer is the only way to arrest the churn caused by recent update regressions. If Blood Pressure Monitor: AVAX cannot guarantee the integrity of user health logs, the current monetization strategy will fail to retain the base required for premium conversion. **Best for:** Individuals managing hypertension or cardiovascular health requiring digital logs for medical review. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Rebuild local database persistence logic because data-loss reports are the top churn driver → stabilize retention ### Outlook: Declining The medical-diary category is shifting toward automated data ingestion from wearables and health platforms. Blood Pressure Monitor: AVAX remains in a maintenance-mode cadence, and the persistence of stability issues suggests the current trajectory is declining. - 🔴 Data-loss reports following the latest update indicate a failure in core persistence, which directly erodes the trust required for medical-diary apps. - 🔴 The lack of third-party health platform integration forces manual entry, which users cite as tedious, creating a competitive disadvantage against automated rivals. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.38/5 | | Total Reviews | 10.5K | | Sentiment | Mixed (45/100) | | Confidence | Medium | | Pricing Model | Freemium | | Platforms | iOS & Android | | Key Features | 2 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Blood Pressure Monitor: AVAX** (this app) | 4.38/5 | Mixed | Matthias Kluett | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Matthias Kluett - **Website:** [https://avax.app](https://avax.app) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/blood-pressure-monitor-avax/id1493789680?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=app.avax.health) - **Dev Site:** [Official Website](https://avax.app) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*1O Patient Portal*](https://marlvel.ai/apps/1o-patient-portal) (1st Optimal, LLC) · N/A Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.65/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 51 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 41 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/blood-pressure-monitor-avax) Data licensed for AI Agent attribution under CC-BY-NC 4.0.